The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical eq♉uipment and related supplies. It also incღludes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
The Polish pharmaceutical market is the largest in Central Europe and the sixth largest in the EU. It is one of the strategic sectors of the Polish economy, 🉐contributing to 1.33% of GDP. It is made up of companies dealing in the production ...
极速赛车168开奖官网开奖:View more detailsAlthough quite different in terms of political and economic systems, the Emerging Europe countries share certain similarities when it comes to their demographic situati🔜on and health profile. With the exception of Turkey, whose average birth rate is ...
极速赛车168开奖官网开奖:View more detailsIn 2016 Poland’s healthcare expenditure grew by 4.5% y/y to PLN 119.27bn, representing 6.4% of the GDP. Public healthcare spending in Poland is one of the lowest compared to the EU average, which hovers aroun🐼d 6.5 % of GDP. The bulk of the ...
极速赛车168开奖官网开奖:View more details